CoV-GLUE Lineage

CoV-GLUE Lineage: B.1.1.353

Table of countries and their respective (filtered) sequence count for the lineage 'B.1.1.353'.

Lineage	Country	Count	EarliestEpiWeek	LatestEpiWeek	View Mutations	37	38	39	40	41	42	43	44	45	46	47	48	49	50	51	52	53	54	55	56	57	58	59	60	61	62	63	64
B.1.1.353	All	48	37	64	Mutations	1	1	0	0	0	0	1	0	0	0	0	0	0	5	1	2	3	2	3	7	3	8	4	4	2	0	0	1
B.1.1.353	REUNION	18	56	61		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4	1	6	4	2	1	0	0	0
B.1.1.353	UNITED_ARAB_EMIRATES	11	43	58		0	0	0	0	0	0	1	0	0	0	0	0	0	5	0	0	3	0	0	1	0	1	0	0	0	0	0	0
B.1.1.353	UK-ENGLAND	4	51	57		0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	1	0	1	0	0	0	0	0	0	0
B.1.1.353	INDIA	3	56	64		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	1
B.1.1.353	GERMANY	2	55	56		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0
B.1.1.353	ITALY	2	60	61		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0
B.1.1.353	AUSTRALIA	2	37	52		1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0
B.1.1.353	LUXEMBOURG	1	58	58		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0
B.1.1.353	JAPAN	1	38	38		0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
B.1.1.353	DENMARK	1	55	55		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0
B.1.1.353	EGYPT	1	54	54		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0
B.1.1.353	ISRAEL	1	52	52		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0
B.1.1.353	SWITZERLAND	1	57	57		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0

CoV-GLUE is still in development. CoV-GLUE was originally developed as part of COG-UK by Josh Singer using the GLUE framework at the MRC-University of Glasgow Centre for Virus Research (CVR). In 2021 it was redeveloped by Richard Orton to scale to the millions of genome sequences available. We acknowledge support from the MRC (MC_UU_12014/12), WT (220977/Z/20/Z) and UKRI G2P (MR/W005611/1). Please contact Richard Orton with any queries: Richard.Orton@glasgow.ac.uk

CoV-GLUE uses sequence data from GISAID. GISAID data provided via this web application is subject to GISAID's Terms and Conditions.